Year Founded
1999
Ownership
Public
Employees
~1000
Stage
Commercial
Modalities
Medical devicesProtein therapeuticsSmall molecule

Auxilium Pharmaceuticals General Information

Commercial stage company with multiple approved products including XIAFLEX for Dupuytren's contracture and Peyronie's disease, Testim and TESTOPEL for hypogonadism, and STENDRA for erectile dysfunction. Pipeline includes Phase 2 programs in frozen shoulder syndrome and cellulite.

Contact Information

Website
Primary Industry
Pharma
Corporate Office

Drug Pipeline

XIAFLEX
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Auxilium Pharmaceuticals's pipeline data

Book a demo

Key Partnerships

Sobi, Asahi Kasei, Actelion, VIVUS, FCB, BioSpecifics, Ferring, Paladin

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Auxilium Pharmaceuticals Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Auxilium Pharmaceuticals's complete valuation and funding history, request access »